Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2025-12-25 @ 12:18 AM
NCT ID:
NCT01326858
Eligibility Criteria:
Inclusion Criteria:
* Able to be dosed in both eyes, to follow instructions, and willing and able to attend required study visits.
* Negative urine pregnancy test if female of childbearing potential and use adequate birth control throughout the study period.
* Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
* History or clinical evidence of ocular herpes simplex or ocular herpes zoster infectious disease.
* History of any clinically significant external ocular disease within 30 days of the start of the study.
* Presence of active blepharitis, active meibomian gland dysfunction, active rosacea affecting the ocular surface/lid margin, active or chronic follicular conjunctivitis, preauricular adenopathy, or any other ocular or periocular abnormality that may affect the study outcomes.
* Other protocol-defined exclusion criteria may apply.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01326858
Study Brief:
Protocol Section:
NCT01326858